BARRETT M JAMES Insider Trading Activity

Average Profitability
15.09%
Insider Buys Quantity
19
Insider Buys Sum
$230.49M
Insider Sells Quantity
16
Insider Sells Sum
$142.2M

Insider Activity of BARRETT M JAMES

Biography of BARRETT M JAMES

No biography is available at this moment.

2018-07-30PurchaseLiquidia Corporation
LQDA
10 percent owner
545,455
4.6996%
$11.00$6M+38.27%
2018-05-10SaleCrescent Biopharma, Inc.
CBIO
9,539
0.0562%
$17.81$169,890-26.95%
2017-11-27SaleAppian Corporation
APPN
10 percent owner
1.14M
2.1156%
$19.49$22.2M+42.78%
2017-11-20SaleAppian Corporation
APPN
10 percent owner
5.64M
11.2735%
$19.49$109.94M+53.66%
2017-10-10PurchaseRhythm Pharmaceuticals, Inc.
RYTM
10 percent owner
550,000
1.3734%
$17.00$9.35M+9.57%
2017-06-01PurchaseSenseonics Holdings, Inc.
SENS
7.09M
6.8398%
$1.41$10M+99.29%
2016-07-18PurchaseArdelyx, Inc.
ARDX
10 percent owner
1.53M
2.9762%
$8.73$13.33M+25.7%
2016-03-23PurchaseSenseonics Holdings, Inc.
SENS
1.58M
2.0277%
$2.85$4.5M+11.5%
2016-01-13PurchaseArdelyx, Inc.
ARDX
10 percent owner
1M
3.0335%
$10.00$10M+4.47%
2015-12-08SaleSupernus Pharmaceuticals, Inc.
SUPN
director
70,913
0.1444%
$14.75$1.05M+26.72%
2015-12-07SaleSupernus Pharmaceuticals, Inc.
SUPN
director
71,067
0.1448%
$14.38$1.02M+29.5%
2015-12-04SaleSupernus Pharmaceuticals, Inc.
SUPN
director
70,990
0.1448%
$14.54$1.03M+27.37%
2015-11-25SaleSupernus Pharmaceuticals, Inc.
SUPN
director
16,179
0.033%
$16.35$264,494+11.94%
2015-11-18SaleSupernus Pharmaceuticals, Inc.
SUPN
director
43,000
0.0879%
$16.50$709,543+8.12%
2015-11-17SaleSupernus Pharmaceuticals, Inc.
SUPN
director
50,000
0.1024%
$16.71$835,460+6.83%
2015-11-16SaleCrescent Biopharma, Inc.
CBIO
452
0.0086%
$6.91$3,123-6.95%
2015-11-16SaleSupernus Pharmaceuticals, Inc.
SUPN
director
19,650
0.0403%
$16.13$317,035+10.55%
2015-11-13SaleSupernus Pharmaceuticals, Inc.
SUPN
director
100,000
0.2052%
$16.26$1.63M+9.07%
2015-06-17SaleSupernus Pharmaceuticals, Inc.
SUPN
111,881
0.239%
$16.39$1.83M+2.25%
2015-06-16SaleSupernus Pharmaceuticals, Inc.
SUPN
55,105
0.1147%
$16.85$928,668-3.37%
Total: 28
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.